• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估抗白细胞介素-8免疫球蛋白G突变体变体的可制造性和关键质量属性概况。

Assessing the Manufacturability and Critical Quality Attribute Profiles of Anti-IL-8 Immunoglobulin G Mutant Variants.

作者信息

Armstrong Georgina Bethany, Burley Glenn A, Lewis William, Rattray Zahra

机构信息

Drug Substance Development, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NFX, U.K.

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, U.K.

出版信息

Mol Pharm. 2024 Dec 2;21(12):6423-6432. doi: 10.1021/acs.molpharmaceut.4c01010. Epub 2024 Nov 7.

DOI:10.1021/acs.molpharmaceut.4c01010
PMID:39509699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11615950/
Abstract

Early-phase manufacturability assessment of high-concentration therapeutic monoclonal antibodies (mAbs) involves screening of process-related risks impacting their translation into the clinic. Manufacturing a mAb at scale relies on cost-effective and robust approaches to derisk manufacturability parameters, such as viscosity, conformational stability, aggregation, and process-related impurities. Using a panel of model anti-IL-8 IgG1 mutants, we investigate upstream and downstream processability, phase behavior, and process-related impurities. We correlate trends in the biophysical properties of mAbs with their cell growth, expression, filtration flux, solubility, and post-translational modifications. We find significant trends in increased relative free light chain expression with heavy chain mutants and detect a requirement for adjusted operation pH for cation exchange polishing steps with charge-altering variants. Moreover, trends between phase stability and high-concentration viscosity were observed. We also investigated unique correlations between increased glycosylation and biophysical behavior. Further in-depth analysis and modeling are required to elucidate the impact of the mAb sequence on the metabolism of the expression system, solubility limits, and alternative gelation models as future directions.

摘要

高浓度治疗性单克隆抗体(mAb)的早期可制造性评估涉及筛选影响其临床转化的工艺相关风险。大规模生产单克隆抗体依赖于具有成本效益且稳健的方法来降低可制造性参数的风险,如粘度、构象稳定性、聚集以及与工艺相关的杂质。使用一组抗IL-8 IgG1模型突变体,我们研究了上下游加工性能、相行为以及与工艺相关的杂质。我们将单克隆抗体的生物物理性质趋势与其细胞生长、表达、过滤通量、溶解度和翻译后修饰相关联。我们发现重链突变体导致相对游离轻链表达增加的显著趋势,并检测到对于电荷改变变体的阳离子交换纯化步骤需要调整操作pH值。此外,观察到了相稳定性和高浓度粘度之间的趋势。我们还研究了糖基化增加与生物物理行为之间的独特相关性。作为未来的方向,需要进一步深入分析和建模以阐明单克隆抗体序列对表达系统代谢、溶解度极限和替代凝胶化模型的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/e63a0a18238d/mp4c01010_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/f436060a5dbc/mp4c01010_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/55aa387433d2/mp4c01010_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/74c0e7b9b614/mp4c01010_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/bb5c6d4f1710/mp4c01010_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/fa002bffadf6/mp4c01010_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/e63a0a18238d/mp4c01010_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/f436060a5dbc/mp4c01010_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/55aa387433d2/mp4c01010_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/74c0e7b9b614/mp4c01010_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/bb5c6d4f1710/mp4c01010_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/fa002bffadf6/mp4c01010_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfce/11615950/e63a0a18238d/mp4c01010_0006.jpg

相似文献

1
Assessing the Manufacturability and Critical Quality Attribute Profiles of Anti-IL-8 Immunoglobulin G Mutant Variants.评估抗白细胞介素-8免疫球蛋白G突变体变体的可制造性和关键质量属性概况。
Mol Pharm. 2024 Dec 2;21(12):6423-6432. doi: 10.1021/acs.molpharmaceut.4c01010. Epub 2024 Nov 7.
2
Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.单克隆抗体减粘突变体的合理设计:疏水与静电分子间相互作用
MAbs. 2015;7(1):212-30. doi: 10.4161/19420862.2014.985504.
3
Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.采用 PEG 诱导沉淀的高通量筛选程序比较在 IgG1 单克隆抗体的制剂开发过程中相对蛋白质溶解度。
J Pharm Sci. 2011 Mar;100(3):1009-21. doi: 10.1002/jps.22350. Epub 2010 Oct 25.
4
Design of next-generation therapeutic IgG4 with improved manufacturability and bioanalytical characteristics.设计具有改善的可制造性和生物分析特性的下一代治疗性 IgG4。
MAbs. 2020 Jan-Dec;12(1):1829338. doi: 10.1080/19420862.2020.1829338.
5
Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.为延长血清半衰期而改造的突变型IgG1单克隆抗体的构象动力学变化与物理稳定性之间的相关性。
MAbs. 2015;7(1):84-95. doi: 10.4161/19420862.2014.985494.
6
Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions.高浓度单克隆抗体制剂中的溶解度挑战:与氨基酸序列及分子间相互作用的关系
Mol Pharm. 2015 Nov 2;12(11):3896-907. doi: 10.1021/acs.molpharmaceut.5b00336. Epub 2015 Oct 6.
7
Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions.人源 IgG1 和 IgG4 S228P 单克隆抗体的黏度和自身相互作用的差异:结构域相互作用的实验评估和计算预测。
MAbs. 2021 Jan-Dec;13(1):1991256. doi: 10.1080/19420862.2021.1991256.
8
Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability.控制稳定转染 CHO 细胞中的 IgG LC:HC 比值及研究其对表达、聚集、糖基化和构象稳定性的影响。
J Biotechnol. 2013 Jun 10;165(3-4):157-66. doi: 10.1016/j.jbiotec.2013.03.019. Epub 2013 Apr 10.
9
Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations.用于对高浓度单克隆抗体制剂进行排名的多标准可制造性指标。
Biotechnol Bioeng. 2017 Sep;114(9):2043-2056. doi: 10.1002/bit.26329. Epub 2017 May 26.
10
In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.用于开发的治疗性抗体的计算机模拟筛选:粘度、清除率和化学稳定性。
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18601-6. doi: 10.1073/pnas.1421779112. Epub 2014 Dec 15.

本文引用的文献

1
A framework for the biophysical screening of antibody mutations targeting solvent-accessible hydrophobic and electrostatic patches for enhanced viscosity profiles.一个用于对靶向溶剂可及疏水和亲水区域的抗体突变进行生物物理筛选以增强粘度特征的框架。
Comput Struct Biotechnol J. 2024 May 24;23:2345-2357. doi: 10.1016/j.csbj.2024.05.041. eCollection 2024 Dec.
2
Tailoring polishing steps for effective removal of polysorbate-degrading host cell proteins in antibody purification.定制抛光步骤以有效去除抗体纯化中聚山梨醇酯降解的宿主细胞蛋白。
Biotechnol Bioeng. 2024 Oct;121(10):3181-3195. doi: 10.1002/bit.28767. Epub 2024 Jun 10.
3
Buffer effects on protein sieving losses in ultrafiltration and their relationship to biophysical properties.
缓冲液对超滤中蛋白质筛分损失的影响及其与生物物理性质的关系。
Biotechnol Prog. 2024 Nov-Dec;40(6):e3481. doi: 10.1002/btpr.3481. Epub 2024 May 23.
4
When will we have a clone? An industry perspective on the typical CLD timeline.我们何时能迎来克隆?从产业角度来看典型的 CLD 时间线。
Biotechnol Prog. 2024 Jul-Aug;40(4):e3449. doi: 10.1002/btpr.3449. Epub 2024 Mar 13.
5
LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies.LAP:通过对天然和治疗性抗体进行序列和结构映射的 Liability Antibody Profiler。
PLoS Comput Biol. 2024 Mar 5;20(3):e1011881. doi: 10.1371/journal.pcbi.1011881. eCollection 2024 Mar.
6
From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies.从效率到产量:探索用于单克隆抗体的中国仓鼠卵巢细胞系开发的最新进展
Mol Biotechnol. 2025 Feb;67(2):369-392. doi: 10.1007/s12033-024-01060-6. Epub 2024 Feb 16.
7
Physical origin of the peak tailing of monoclonal antibodies in size-exclusion chromatography using bio-compatible systems and columns.使用生物兼容系统和柱子的排阻色谱法中单克隆抗体峰尾部拖尾的物理起源。
Anal Bioanal Chem. 2024 Feb;416(5):1281-1291. doi: 10.1007/s00216-023-05119-2. Epub 2024 Jan 18.
8
Antibody sequence-based prediction of pH gradient elution in multimodal chromatography.基于抗体序列的多峰色谱 pH 梯度洗脱预测。
J Chromatogr A. 2023 Nov 22;1711:464437. doi: 10.1016/j.chroma.2023.464437. Epub 2023 Oct 11.
9
Analytical Techniques for the Characterization and Quantification of Monoclonal Antibodies.单克隆抗体表征与定量分析技术
Pharmaceuticals (Basel). 2023 Feb 14;16(2):291. doi: 10.3390/ph16020291.
10
Digital twin of a continuous chromatography process for mAb purification: Design and model-based control.单抗纯化连续色谱过程的数字孪生:设计和基于模型的控制。
Biotechnol Bioeng. 2023 Mar;120(3):748-766. doi: 10.1002/bit.28307. Epub 2022 Dec 27.